Medicines labeled for the same conditions
Alternatives to alfuzosin
6 other medicines are given the same way (oral) and in the same FDA class as alfuzosin or labeled mainly for the same use (enlarged prostate (bph)); 4 are in its class, alpha-adrenergic blockers: doxazosin, terazosin, tamsulosin and silodosin; the others include 2 5-alpha reductase inhibitors (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.05 per tamsulosin HCl 0.4 mg capsule (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as alfuzosin?
Enlarged prostate (BPH) lists all 8 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Alfuzosinalpha-adrenergic blocker | this medicine | 10 labelers | $0.105 per tablet 10 mg tablet | No | No current entry |
| Doxazosinalpha-adrenergic blocker · same class | Enlarged prostate (BPH) | 29 labelers | $0.0752 per tablet 1 mg tablet | No | No current entry |
| Terazosinalpha-adrenergic blocker · same class | Enlarged prostate (BPH) | 21 labelers | $0.106 per capsule 2 mg capsule | No | No current entry |
| Tamsulosinalpha-adrenergic blocker · same class | Enlarged prostate (BPH) | 37 labelers | $0.05 per capsule 0.4 mg capsule | No | No current entry |
| Silodosinalpha-adrenergic blocker · same class | Enlarged prostate (BPH) | 13 labelers | $0.319 per capsule 8 mg capsule | No | No current entry |
| Finasteride5-alpha reductase inhibitor | Enlarged prostate (BPH) | 30 labelers | $0.0688 per tablet 5 mg tablet | No | No current entry |
| Dutasteride5-alpha reductase inhibitor | Enlarged prostate (BPH) | 13 labelers | $0.157 per capsule 0.5 mg capsule | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Alfuzosin: the full record
- label, generics, price, shortages, recalls
- Alfuzosin vs doxazosin
- two records side by side
- Alfuzosin vs terazosin
- two records side by side
- Alfuzosin vs tamsulosin
- two records side by side
- Silodosin vs alfuzosin
- two records side by side